1. Home
  2. HQL vs MTLS Comparison

HQL vs MTLS Comparison

Compare HQL & MTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HQL
  • MTLS
  • Stock Information
  • Founded
  • HQL 1992
  • MTLS 1990
  • Country
  • HQL United States
  • MTLS Belgium
  • Employees
  • HQL N/A
  • MTLS N/A
  • Industry
  • HQL Investment Managers
  • MTLS Computer Software: Prepackaged Software
  • Sector
  • HQL Finance
  • MTLS Technology
  • Exchange
  • HQL Nasdaq
  • MTLS Nasdaq
  • Market Cap
  • HQL 369.6M
  • MTLS 349.7M
  • IPO Year
  • HQL N/A
  • MTLS 2014
  • Fundamental
  • Price
  • HQL $13.14
  • MTLS $5.02
  • Analyst Decision
  • HQL
  • MTLS
  • Analyst Count
  • HQL 0
  • MTLS 0
  • Target Price
  • HQL N/A
  • MTLS N/A
  • AVG Volume (30 Days)
  • HQL 120.9K
  • MTLS 118.4K
  • Earning Date
  • HQL 01-01-0001
  • MTLS 07-24-2025
  • Dividend Yield
  • HQL 11.56%
  • MTLS N/A
  • EPS Growth
  • HQL N/A
  • MTLS N/A
  • EPS
  • HQL 0.79
  • MTLS 0.11
  • Revenue
  • HQL N/A
  • MTLS $311,850,851.00
  • Revenue This Year
  • HQL N/A
  • MTLS $5.28
  • Revenue Next Year
  • HQL N/A
  • MTLS $7.82
  • P/E Ratio
  • HQL $17.08
  • MTLS $47.46
  • Revenue Growth
  • HQL N/A
  • MTLS 2.98
  • 52 Week Low
  • HQL $11.34
  • MTLS $3.93
  • 52 Week High
  • HQL $14.37
  • MTLS $9.69
  • Technical
  • Relative Strength Index (RSI)
  • HQL 51.20
  • MTLS 34.00
  • Support Level
  • HQL $13.25
  • MTLS $5.14
  • Resistance Level
  • HQL $13.44
  • MTLS $5.57
  • Average True Range (ATR)
  • HQL 0.24
  • MTLS 0.24
  • MACD
  • HQL -0.03
  • MTLS -0.10
  • Stochastic Oscillator
  • HQL 41.54
  • MTLS 7.87

About HQL abrdn Life Sciences Investors Shares of Beneficial Interest

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.

About MTLS Materialise NV

Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.

Share on Social Networks: